Ethynyl estradiol is a synthetic potent estrogen widely applied in pharmaceutical industry as core raw material for clinical hormonal preparations. Its dominant application lies in combined oral contraceptive pills, compounded with progestogen ingredients to suppress ovulation by inhibiting pituitary gonadotropin secretion, serving as mainstream contraceptive raw material globally. In gynecological treatment, it remedies primary and secondary amenorrhea caused by ovarian insufficiency, irregular dysfunctional uterine bleeding and hypoestrogenism symptoms from premature ovarian failure. It is also prescribed for perimenopausal hormone replacement therapy to ease hot flashes, vaginal dryness and osteoporosis induced by endogenous estrogen decline. Additionally, it assists in treating advanced prostate cancer via suppressing androgen activity through endocrine regulation. Veterinary pharmaceutical field adopts qualified grades for reproductive disorder therapy of domestic animals under strict veterinary prescription control. All finished medicines containing this compound are classified prescription-only drugs, prohibiting arbitrary formulation without pharmaceutical production authorization.
Ethynyl estradiol carries evident hormonal side effects and strict administration restrictions for human safety. Short-term oral intake may trigger gastrointestinal upset including nausea, vomiting and bloating, alongside breast tenderness, breast enlargement and irregular spotting in female patients. Long-term excessive use sharply elevates risks of venous thromboembolism, cerebral thrombosis and hepatic metabolic burden, potentially inducing abnormal liver enzyme elevation and gallbladder lesions. It is contraindicated for patients with liver dysfunction, severe cardiovascular disease, breast or endometrial malignant tumor and undiagnosed genital bleeding. Pregnant women and breastfeeding females are forbidden to take relevant formulations. Occupational exposure requires gloves and dust-proof mask to avoid inhalation of fine powder which may cause endocrine disturbance for operators. Waste residue and discarded samples must follow hazardous pharmaceutical waste disposal rules instead of direct drainage into water system. Unlawful abuse for body shaping or performance improvement brings irreversible endocrine disorder and organ damage.
